BCL2 and ovarian cancer: In addition, Bcl-2 downregulation in SK-OV-3 ovarian cancer cells increases Ca2+ levels in the cytosol and in the mitochondria, as well as the number of ER–mitochondrial contact points after cisplatin treatment, thereby increasing the sensitivity to the chemotherapeutic agent [80].